Author:
Schmidt K.L. Juliëtte,Severeijns Noortje R.,Dautzenberg Noël M.M.,Hoogerbrugge Peter M.,Lindemans Caroline A.,Nierkens Stefan,Smits Gaby,van Binnendijk Rob S.,Fiocco Marta,Bont Louis J.,Tissing Wim J.E.
Reference16 articles.
1. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study;Mukkada;Lancet Oncol.,2021
2. National Institute for Public Health and the Environment (RIVM), Implementation Guidelines for COVID-19 Vaccination, 2023, version 4.3. Published 2023. Accessed 7 July 2023. 〈https://lci.rivm.nl/richtlijnen/covid-19-vaccinatie〉.
3. SARS-CoV-2 vaccination response in pediatric oncology patients;D'Souza;Pediatr. Blood Cancer,2024
4. Reducedhumoral response against variants of concern in childhood solid cancer patients compared to adult patients and healthy children after SARS-CoV-2 vaccination;Ma;Front. Immunol.,2023
5. Immune Response after 2 doses of BNT162b2 mRNA COVID-19 vaccinations in children and adolescents with cancer and hematologic diseases;Poparn;Asian Pac. J. Cancer Prev.,2022